Govinda Bhisetti is a Principal Investigator and Head of the Computational Chemistry department at Biogen since 2014. Previously, he worked at Vertex Pharmaceuticals for 22+ years where he led drug design efforts on several drug discovery projects. His research at Vertex led to the discovery of three FDA approved drugs: Agenerase, Lexiva, and Incivek. He is a co-inventor of these drugs and named inventor on 26 patents. He has also published 74 research papers including review articles and book chapters. His current activities include the application of state of the art computational methods in the discovery of novel drugs for CNS diseases.
Govinda
